Conexeu Sciences

Update in progress

CNXU (NasdaqCM)

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffolds for medical aesthetics and tissue repair. It offers patented collagen extracellular matrix (ECM) scaffold platforms for aesthetic procedures, wound care, facial rejuvenation, and large-volume body contouring, including face, breast, and butt volume restoration. Its CXU collagen gel is investigational, aiming to support tissue regeneration with reduced inflammation or fibrosis. Based in Reno, Nevada, founded 2022; products are investigational and pending regulatory clearance. Serves clinicians in aesthetics, regenerative medicine, and medical sectors.